European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Glaxo Wellcome UK Ltd., Stevenage

Watch
Glaxo Wellcome UK Ltd.

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Glaxo Wellcome UK Ltd.
Glaxo Pharmaceuticals UK Ltd.
Glaxo Export Ltd.
Laminated Plastic Products Ltd.

Identification

Chp
Companies House 00480080
Lei
213800H7QV93VB5S3154

Address

Gunnels Wood Road, Gsk Medicines Research Centre, Stevenage SG1 2NY, United Kingdom
980 Great West Road Brentford Middlesex, United Kingdom
Glaxosmithkline Great West Road Brentford Middlesex, United Kingdom

Corporate purpose

46.46
Wholesale of pharmaceutical goods

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Total assets

For this company, Total assets numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
4Director
1Secretary
2Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Taxes
Receivables
Liabilities
Patents
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

11 Sept 2026
Audit exemption subsidiary accounts made up to 2025-12-31
11 Sept 2026 also 21/08/2026, 19/08/2025, 17/08/2024, 18/08/2023, 18/08/2022, 20/05/2021, 02/06/2020
Consolidated accounts of parent company for subsidiary company period ending 31/12/25
11 Sept 2026 also 17/08/2024, 18/08/2022, 20/02/2020
Audit exemption statement of guarantee by parent company for period ending 31/12/25 …
21 Aug 2026 also 04/10/2021
Notice of agreement to exemption from audit of accounts for period ending 31/12/25
20 Apr 2026 also 31/07/2025, 16/08/2024, 10/08/2021, 25/08/2020, 29/08/2019, 28/08/2018, 15/08/2017
Confirmation statement made with no updates
19 Aug 2025
Annual report for the year ending 31/12/2024
19 Aug 2025 also 18/08/2023
Notice of agreement to exemption from audit of accounts for period ending 31/12/24 …
16 Jul 2025
Director: Anna M. H. Fent
9 Jul 2025
No longer Director: Jemma-L. Reynolds
12 Oct 2024
Annual report for the year ending 31/12/2023
27 Sept 2024
Director: C. Barcelo Igles
23 Sept 2024
Secretary's details changed for Mrs Victoria Anne Whyte
20 Sept 2024
Director's details changed for Mrs Demet Gurunlu Russ
17 Sept 2024
Director's details changed for Mrs Jemma-Louise Reynolds · Director's details changed for Mr Graham Paul Rivers …
31 Jul 2024
No longer Director: Gregory M. Reinaud
18 Jul 2024
Address
12 Jul 2024
Appointment of Mrs Demet Gurunlu Russ as a director
5 Jul 2024
No longer Director: Jill Dawn Anderson
15 Apr 2024
Director: Jemma-L. Reynolds
2 Feb 2024
Director: Gregory M. Reinaud
20 Sept 2023
No longer Director: Ziba Shamsi
18 Aug 2023
Annual report for the year ending 31/12/2022
16 Aug 2023
Director's details changed for Glaxo Group Limited
15 Aug 2023
Companies House - Filing
2 Aug 2023
Director: Graham Paul Rivers
9 Jun 2023
Address
6 Jun 2023
Address
3 Mar 2023
Director: Jill Dawn Anderson
2 Mar 2023
No longer Director: Jerome Andries
16 Dec 2022
Patent: Treatment of Respiratory Virus Infection by Modulation of the N-Glycosylation Pathway
15 Dec 2022
Patent: Heterocycle Derivatives for the Treatment of Disease
3 Nov 2022
Director: Ziba Shamsi
2 Nov 2022
Termination of appointment of Kate Sophie Priestman as a director
31 Aug 2022
Patent: Antibody Therapies for Sars-COV-2 Infection in Pediatric Subjects
18 Aug 2022
Annual report for the year ending 31/12/2021
6 Jun 2022
Memorandum and Articles of Association · Resolution of adoption of Articles of Association (ADOPT ARTICLES) …
4 Oct 2021
Annual report for the year ending 31/12/2020
20 May 2021
Audit exemption statement of guarantee by parent company for period ending 31/12/20
11 May 2021
Appointment of Ms Kate Sophie Priestman as a director
25 Nov 2020
No longer Director: Ciara Martha Lynch
24 Nov 2020
Director: Jerome Andries
22 Jun 2020
Annual report for the year ending 31/12/2019
18 Mar 2020
Director: Ciara Martha Lynch · No longer Director: James Borger, Ch. Panagiotidis
27 Jun 2019
Annual report for the year ending 31/12/2018
4 Apr 2019
No longer Director: Alan George Burns
12 Mar 2019
Director: Ch. Panagiotidis
28 Feb 2019
Director: James Borger
18 Feb 2019
No longer Director: Oleg Dubianskij
29 Mar 2018
Annual report for the year ending 31/12/2017
11 Apr 2017
Annual report for the year ending 31/12/2016
6 Feb 2017
Director: Oleg Dubianskij
22 Aug 2016
Confirmation statement made with updates
17 Jun 2016 also 15/04/2015, 10/04/2014, 27/03/2013, 28/05/2012, 01/04/2011, 15/03/2010, 26/03/2009, 11/03/2008, 31/08/2007, 25/07/2006, 08/04/2005
Full accounts made up to 2015-12-31
27 Aug 2015
Capital: £65M
18 Aug 2014
Capital: £65M
12 Sept 2013
Address
28 Aug 2013
Capital: £65M
18 Dec 2012
No longer Director (1)
6 Dec 2012
Director: Alan George Burns
14 Sept 2012 also 08/09/2010
Annual return made up to 2012-08-15 with full list of shareholders
23 Sept 2011
Address
21 Oct 2010
No longer Director (1)
14 Sept 2010
Director (1)
7 Sept 2010
Director's details changed for Glaxo Group Limited · Director's details changed for Edinburgh Pharmaceutical Industries …
6 Sept 2010
Address
14 Oct 2009
Address
18 Sept 2009
Director (1)
19 Aug 2009 also 08/09/2008, 20/09/2007
Return made up to 15/08/09; full list of members
26 Sept 2006
Return made up to 15/08/06; full list of members · Secretary's particulars changed
26 Apr 2006
Secretary's particulars changed
6 Sept 2005
Return made up to 15/08/05; full list of members · Director's particulars changed
There are no publications matching your search.

Mentions

13 May 2026 in Ler
Direct parent
13 May 2026 in Ler
Ultimate parent
18 Jul 2024 in Psc
Companies House - Persons with Significant Control
11 Dec 2020 in Psc
Companies House - Persons with Significant Control
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.